Personalis, Inc.

NASDAQ:PSNL

Medical - Diagnostics & Research

Healthcare
$14.98 +3.44%

+$0.34 today

Market cap
$1.62B
Beta
2.28
P/E (TTM)
-11.0
EPS (TTM)
-$0.92
52W Low $3.84High $12.53

Volume 1.47M

Average 2.31M

PSNL Inventory

Raw materials, work in progress, and finished goods held for sale.

Personalis, Inc.NASDAQ: PSNL

Inventory · Q1 FY2026 · quarter ended Mar 2026

Inventory rises 64.5% from a year ago

Inventory stood at $6.93M at the end of Q1 FY2026, up 64.5% from a year earlier and up 12.8% from the prior quarter. Over 3 fiscal years it compounded at -1.3% a year.

Context

  • Inventory amounted to 2.1% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
  • Inventory increased in 1 of the last 3 fiscal years.

What to watch

Whether inventory keeps rising in the next quarterly balance sheet after a +64.5% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$6.93M+12.8% QoQ
Last fiscal yearDec 2025
$6.14M+54.5% YoY
Year agoMar 2025
$4.21M+64.5% since
Inventory past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+64.5%——
1 year+54.5%——
3-year CAGR-1.3%——
5-year CAGR——
10-year CAGR——

Inventory history

USD · from the balance sheet

Latest · FY2025
6.14M USD
Year-over-year change
+54.5%
4-year CAGR
+10.8%

Inventory vs competitors

How PSNL compares with its peers on the latest reported figures

  • PSNL's Mar 2026 inventory of $6.93M is the 9th highest of the 10 companies compared; the peer median is $22.66M.
  • Its year-over-year change of +64.5% is the highest of 10, against a peer median of -1.4%.
  • Inventory amounts to 2.1% of total assets for PSNL, versus a peer median of 2.9%.
PSNL Competitors Peer median
Inventory for PSNL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
GHGuardant Health, Inc.Sep 2026$93.49M +3.3%+18.5%5.0%
NTRANatera, Inc.Jun 2026$80.35M +48.0%+24.6%3.0%
MYGNMyriad Genetics, Inc.Mar 2026$27.9M -1.4%+15.0%4.1%
NEONeoGenomics, Inc.Jun 2026$27.14M -20.6%+5.6%2.0%
VCYTVeracyte, Inc.Jun 2026$22.66M -9.4%+12.9%1.5%
BLLNBillionToOne, Inc.Jun 2026$21.14M +53.9%—2.9%
WGSGeneDx Holdings Corp.Jun 2026$17.82M +49.3%+0.7%3.7%
GRALGRAIL, Inc.Jun 2026$17.76M -10.0%-6.8%0.6%
PSNLPersonalis, Inc.Mar 2026$6.93M +64.5%-1.3%2.1%
FLGTFulgent Genetics, Inc.Mar 2026$770K -91.1%+35.3%0.1%
Peer median (excluding PSNL) $22.66M-1.4%+13.9%2.9%

Competitors are the stored peer set for PSNL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents105.59M89.13M56.98M91.42M124.25M
Short-term Investments181.48M78.53M57.2M93.59M115.71M
Net Receivables18.47M16.64M17.73M8.14M16.2M
Inventory4.08M6.38M5.66M3.98M6.14M
Other Current Assets1.53M9.02M9.17M5.89M5.65M
Total Current Assets318.23M199.7M146.74M203.02M267.95M
Property, Plant & Equipment (Net)73.47M88.42M75.22M64.73M59.93M
Goodwill00000
Intangible Assets00000
Long-term Investments00000
Tax Assets00000
Other Non-current Assets4.83M4.59M3.14M2.53M6.28M
Total Non-current Assets78.3M93M78.36M67.25M66.21M
Total Assets396.53M292.7M225.1M270.27M334.16M
Account Payables9.22M12.85M14.92M6.4M12.99M
Short-term Debt1.81M2.22M1.65M1.67M1.19M
Tax Payables121K123K37K00
Deferred Revenue4.36M1.29M3.29M3.1M1.56M
Other Current Liabilities11.19M9.55M19.62M10.86M12.8M
Total Current Liabilities31.31M33.13M47.23M31.13M39.63M
Long-term Debt000031.87M
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities2.12M389K10.1M1.3M1.48M
Total Non-current Liabilities54.91M41.43M48.42M36.19M33.35M
Total Liabilities86.23M74.56M95.66M67.31M72.98M
Common Stock4K5K5K9K10K
Retained Earnings(247.1M)(360.41M)(468.71M)(549.99M)(631.26M)
Accumulated OCI(166K)(912K)(222K)(23K)104K
Other Stockholders Equity00000
Minority Interest00000
Total Equity310.3M218.14M129.44M202.96M261.19M
Total Debt58.33M48.65M47.73M44.25M39.95M
Net Debt(47.25M)(40.48M)(9.26M)(47.17M)(84.3M)

Personalis, Inc.

NASDAQ:PSNL

Intrinsic Alpha fair value

Locked

Current Price

$14.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.